New first-line treatment algorithm for advanced NSCLC.
ALK, anaplastic lymphoma kinase; EGFR, epidermal growth factor receptor;
FISH, fluorescent in situ hybridization; IHC, immunohistochemistry; NSCLC,
non-small cell lung cancer; PD-L1, programmed death-ligand 1; TTF, thyroid
transcription factor.